08:54 AM EST, 12/03/2024 (MT Newswires) -- Health care stocks were steady premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) inactive.

Coherus BioSciences ( CHRS ) shares were up past 53% after the company said it has agreed to divest its biosimilar drug Udenyca, which is based on Amgen's ( AMGN ) Neulasta, to Intas Pharmaceuticals for up to $558.4 million.